logo
  

Korn Ferry Q4 Profit Tops Estimates; Fee Revenue Up 33% At Constant Currency

Korn Ferry (KFY) reported fourth quarter adjusted earnings per share of $1.75 compared to $1.21, prior year. On average, five analysts polled by Thomson Reuters expected the company to report profit per share of $1.55, for the quarter. Analysts' estimates typically exclude special items. Adjusted EBITDA margin was 20.0% compared to 20.3%, last year.

Net income attributable to Korn Ferry was $91.7 million compared to $66.2 million, last year. Earnings per share was $1.70 compared to $1.21.

The company reported fee revenue of $721.1 million, an increase of 30%, or up 33% on a constant currency basis. Total revenue increased to $727.00 million from $557.39 million. Analysts on average had estimated $680.71 million in revenue.

Korn Ferry projects first quarter fee revenue to be in the range of $680 million and $710 million; and earnings per share to range between $1.35 to $1.51. The company expects adjusted earnings per share to be in the range from $1.42 to $1.58.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT